PAULSON & CO INC 13D and 13G filings for Madrigal Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 5:18 pm Purchase |
2024-09-30 | 13G | Madrigal Pharmaceuticals, Inc. MDGL |
PAULSON & CO INC | 2,042,000 9.400% |
936,259 (+84.67%) |
Filing |
| 2024-02-14 4:47 pm Purchase |
2023-12-31 | 13G | Madrigal Pharmaceuticals, Inc. MDGL |
PAULSON & CO INC | 1,105,741 5.600% |
105,741 (+10.57%) |
Filing |
| 2023-11-13 4:39 pm Purchase |
2023-11-01 | 13G | Madrigal Pharmaceuticals, Inc. MDGL |
PAULSON & CO INC | 1,000,000 5.100% |
1,000,000 (New Position) |
Filing |